Effects of Inbreeding Depression on Disease Resistance

Loading

  • Inbreeding depression can influence disease resistance, disease susceptibility, immune function, survival, and overall health in animal populations. When related animals are mated, their offspring have an increased probability of inheriting identical copies of alleles from common ancestors. This increases homozygosity and autozygosity and can expose deleterious recessive alleles that may negatively affect immune function and the ability of animals to resist infectious diseases.
  • Disease resistance is an important component of animal health, productivity, welfare, survival, and long-term breeding efficiency. Animals that are genetically better able to resist infection may experience fewer clinical diseases, lower pathogen burdens, reduced treatment requirements, and better production under disease challenge. However, disease resistance is influenced by many genetic and environmental factors, so inbreeding should be considered as one component of a much broader biological system.
  • The genetic basis of inbreeding depression begins with common ancestry and identity by descent (IBD). When two related parents are mated, the probability increases that an offspring receives the same ancestral allele through both parental lines. This can create regions of autozygosity, where the two copies of DNA are inherited from a common ancestor.
  • The expected inbreeding coefficient of an offspring can be expressed using the kinship between its parents:
  • E(F_offspring) = φ(sire, dam)
  • Using the conventional coefficient of relationship:
  • E(F_offspring) = r(sire, dam) / 2
  • These are expected probabilities rather than guarantees for an individual offspring. Mendelian sampling and recombination mean that offspring from the same parents can inherit different chromosome segments and therefore have different realized genomic levels of homozygosity.
  • Disease resistance is a complex biological trait involving interactions among the host genome, pathogen, environment, nutrition, management, and immune system. A useful conceptual model for observed disease-related performance is:
  • P = G + E
  • where P is the observed phenotype, G represents genetic effects, and E represents environmental effects. More complete genetic models may also include maternal effects, permanent environmental effects, common environmental effects, genotype–environment interaction, and other sources of variation.
  • Disease resistance generally refers to the ability of an animal to prevent infection, restrict pathogen establishment or replication, or reduce the biological consequences of infection. It should be distinguished from disease tolerance, which refers to the ability to maintain health or performance despite infection. An animal can therefore be relatively susceptible to infection but still tolerate the infection well, while another animal may resist infection effectively.
  • Inbreeding can potentially reduce disease resistance through several genetic mechanisms. Increased homozygosity can expose deleterious recessive alleles affecting immune development, immune signaling, cellular function, barrier integrity, metabolism, or other biological processes involved in host defense. Reduced heterozygosity may also influence immune-related performance at particular loci.
  • The immune system consists of interconnected components that provide defense against pathogens. These include physical barriers, innate immune mechanisms, adaptive immune responses, immune cells, antibodies, cytokines, complement pathways, inflammatory processes, and immunological memory. Genetic variation contributes to differences in the function and regulation of these systems.
  • The innate immune system provides rapid, relatively nonspecific defense against pathogens. It includes skin and mucosal barriers, antimicrobial molecules, complement, phagocytic cells, inflammatory responses, and other mechanisms. Genetic variants affecting these systems can influence susceptibility to infectious disease.
  • The adaptive immune system provides more specific responses and includes B cells, T cells, antibodies, antigen recognition, and immunological memory. Genetic variation in genes involved in antigen presentation and immune recognition can influence how animals respond to different pathogens.
  • The major histocompatibility complex (MHC) and related antigen-presentation systems are particularly important because they influence how immune cells recognize foreign molecules. Genetic diversity in immune-related loci can therefore contribute to variation in disease resistance. However, disease resistance is generally polygenic and cannot be explained by one immune gene or one genetic marker alone.
  • Inbreeding may reduce genetic variation at immune-related loci. In populations with high levels of related mating, alleles that would normally occur in heterozygous combinations can become homozygous. If some of these alleles have harmful effects, disease resistance may decline.
  • The dominance hypothesis provides one explanation for this pattern. Under this hypothesis, deleterious recessive alleles are more likely to be expressed when increased homozygosity causes them to occur in homozygous form. Their expression can impair physiological functions, including immune defense.
  • The overdominance hypothesis provides another possible mechanism. At some loci, heterozygous genotypes may have greater biological performance than either homozygous genotype. Increased homozygosity could therefore reduce the performance advantage associated with heterozygosity.
  • Epistasis, or interactions among genes, can also contribute to variation in immune function and disease resistance. The effect of one locus may depend on the genotype at another locus. Increasing homozygosity can alter these genetic combinations and potentially affect complex immune phenotypes.
  • The overall effect of inbreeding on disease resistance therefore depends on the genetic architecture of the trait. Some disease-resistance traits may show measurable inbreeding depression, while others may show weak or inconsistent associations. The magnitude of the effect can differ among pathogens, breeds, populations, and environments.
  • Disease resistance is also strongly influenced by environmental exposure. Animals cannot show the same disease phenotype if they are never exposed to the relevant pathogen. Consequently, genetic evaluations of disease resistance require accurate information about exposure, infection status, clinical disease, management, and environmental conditions.
  • This is one reason why disease resistance can be more difficult to measure than traits such as body weight. A healthy animal may be genetically resistant, or it may simply have experienced lower pathogen exposure. Genetic evaluation must therefore distinguish genetic resistance from differences in exposure and management whenever possible.
  • Genotype–environment interaction (G×E) can further complicate the relationship between inbreeding and disease resistance. An animal’s genetic advantage may be more apparent under high pathogen pressure than under low disease exposure. Similarly, genetic differences in immune performance may become more important when animals experience nutritional stress, heat stress, poor housing, or other environmental challenges.
  • Nutrition is particularly important. Adequate energy, protein, minerals, vitamins, and other nutrients are necessary for normal immune function. If inbred animals are also exposed to nutritional deficiencies, the combined effects may be greater than either factor alone.
  • Management practices also influence disease outcomes. Biosecurity, vaccination, hygiene, stocking density, housing, ventilation, parasite control, sanitation, quarantine, and veterinary treatment can strongly affect disease incidence. Genetic improvement for disease resistance should therefore complement rather than replace effective management.
  • Inbreeding can also influence disease resistance indirectly through growth, fertility, survival, and general physiological fitness. Animals experiencing inbreeding depression in multiple biological systems may have reduced capacity to respond to disease challenges. Poor growth or inadequate nutritional reserves can make animals more vulnerable to infection and slower to recover.
  • The relationship between disease resistance and survival is especially important. If genetically susceptible animals experience more severe infections, disease can increase mortality. Inbreeding may therefore contribute to reduced survival indirectly through increased disease susceptibility.
  • Similarly, disease can affect growth. Animals suffering from chronic or repeated infections may allocate nutrients and energy toward immune responses rather than growth or production. Consequently, an association between inbreeding and lower growth may partly reflect increased disease burden.
  • Disease susceptibility is not exactly the same as disease resistance. Disease susceptibility describes the likelihood or degree to which an animal becomes affected by a disease, whereas resistance refers to the ability to prevent or limit infection. Both concepts can be genetically influenced and can be studied in breeding programs.
  • Some health traits are recorded as binary outcomes, such as diseased versus healthy. Such traits are often analyzed using threshold models, in which an underlying continuous genetic liability determines whether an observable disease outcome occurs after crossing a threshold.
  • For a binary disease trait, an animal may be recorded as:
  • Disease status = 0 or 1
  • where 0 may represent no recorded disease and 1 may represent disease. However, the underlying genetic liability is not itself necessarily binary. It may reflect many genes and environmental factors acting together.
  • Disease resistance can also be measured using more quantitative traits, including pathogen load, parasite burden, antibody response, cell-mediated immune response, somatic cell count, lesion score, disease severity, recovery time, or repeated disease incidence. The most appropriate measurement depends on the species and disease.
  • Heritability is important when evaluating the potential for genetic improvement. A disease-resistance trait with non-zero heritability can respond to selection, even if environmental effects are substantial. However, low heritability does not mean that genetics are unimportant or that selection is impossible. It means that environmental variation contributes strongly to observed differences.
  • Genetic correlations between disease resistance and other traits are also important. Disease resistance may be genetically related to fertility, growth, production, longevity, feed efficiency, temperament, resilience, or other health traits. Favorable genetic correlations can make simultaneous improvement easier, while unfavorable correlations may create trade-offs.
  • A selection index can combine disease resistance with production, fertility, survival, welfare, and other economically or biologically important traits. This allows breeders to select animals according to an overall breeding objective rather than maximizing a single disease-resistance measurement.
  • Inbreeding can also influence the expression of genetic load. Genetic load includes deleterious genetic variants that reduce fitness under certain circumstances. Increased homozygosity can increase the probability that harmful recessive variants are expressed.
  • The effect of genetic load on disease resistance may be particularly important when immune function depends on many genes. An animal can carry multiple mildly deleterious variants without obvious clinical effects, but increased homozygosity may increase their combined biological consequences.
  • Population history is therefore important. Populations that have experienced severe genetic bottlenecks, founder effects, prolonged isolation, or repeated related mating may have different genetic loads and disease-resistance profiles from genetically diverse populations.
  • Genetic drift can further change allele frequencies in small populations. When effective population size is small, random changes in allele frequency become stronger. This can cause loss of beneficial immune-related alleles or increase the frequency of deleterious variants.
  • The effective population size can be related to the expected rate of inbreeding using the simplified relationship:
  • ΔF ≈ 1 / (2Ne)
  • where ΔF is the expected increase in inbreeding per generation and Ne is effective population size.
  • This relationship is based on simplified assumptions, and real breeding populations often deviate from them. Unequal family sizes, unequal reproductive contribution, selection, sex ratio, overlapping generations, population structure, and reproductive technologies can all influence the realized rate of inbreeding.
  • The popular sire effect is particularly relevant. A small number of heavily used sires can contribute a large proportion of the next generation. If these sires become widely related to the rest of the population, future matings can involve increasingly related animals.
  • Artificial insemination and embryo transfer can accelerate genetic improvement but can also increase reproductive concentration. Therefore, their use should be combined with appropriate management of genetic relationships and genetic diversity.
  • Pedigree records can help identify related animals and estimate expected inbreeding. However, pedigree information describes expected relationships based on recorded ancestry. It does not show the exact chromosome segments inherited by each individual.
  • Genomic relatedness provides information about realized genetic similarity. SNP genotyping can reveal shared genomic segments, homozygosity, and relationships that may differ from pedigree expectations.
  • Runs of homozygosity (ROH) are continuous genomic regions containing homozygous markers. They can provide information about autozygosity and historical or recent common ancestry. Long ROH are often associated with more recent shared ancestry, whereas shorter ROH can reflect older demographic events, although interpretation depends on population history and analytical criteria.
  • A commonly used genomic measure is:
  • F_ROH = Total length of ROH / Total autosomal genome length
  • F_ROH estimates the proportion of the autosomal genome contained in detected ROH. It can be useful for monitoring genomic inbreeding and identifying animals or populations with high levels of homozygosity.
  • Genomic information may also help identify cryptic relatedness, where animals appear unrelated or only distantly related from incomplete pedigrees but share substantial genomic segments. This can improve mating decisions and help reduce unexpected increases in inbreeding.
  • Modern breeding programs can combine pedigree information and genomic information. The pedigree-based relationship matrix, commonly called the A matrix, represents expected additive relationships, whereas a genomic relationship matrix, commonly called the G matrix, reflects realized relationships based on DNA markers.
  • Combining these sources of information can improve genetic evaluation. BLUP, animal models, and genomic evaluation can be used to estimate breeding values for disease resistance and related health traits.
  • Genomic selection can be particularly valuable for disease resistance because some disease traits are difficult, expensive, late in life, or ethically challenging to measure directly. Genomic prediction can allow selection of young animals based on genetic information before extensive disease records are available.
  • However, genomic selection should not be implemented solely to maximize selection intensity. If a small number of genomically superior animals become heavily used, genetic diversity may decline and the rate of inbreeding may increase.
  • Mate allocation can help address this problem. Breeding programs can select genetically superior animals while avoiding mating combinations that create excessive expected inbreeding. Genomic relationships can improve the accuracy of these decisions.
  • Optimal contribution selection takes the process further by controlling the genetic contribution of selected animals to the next generation. The objective is to maximize genetic progress while maintaining an acceptable rate of inbreeding and preserving genetic diversity.
  • Disease resistance can also benefit from maintaining genetic diversity within populations. A diverse population contains more genetic variation that may contribute to responses against current and future pathogens. Maintaining diversity can therefore improve the long-term adaptability of a breeding population.
  • This is particularly important because pathogens evolve. A breeding program that optimizes resistance to one disease under current conditions may not automatically produce animals with broad resistance to future pathogens. Maintaining genetic variation can provide greater long-term flexibility.
  • Heterozygosity can also contribute to population-level resilience. Crossbreeding between genetically differentiated populations can increase heterozygosity and produce heterosis, which may improve fitness-related traits including survival, fertility, and disease resistance in some production systems.
  • The magnitude of heterosis depends on the genetic distance between parental populations, trait, environment, and breed combination. Crossbreeding is therefore not a universal replacement for within-breed genetic selection but can be an important complementary strategy.
  • The effects of inbreeding on disease resistance should also be interpreted in the context of disease tolerance. Resistance and tolerance are biologically different strategies. Selection for resistance may reduce pathogen infection or burden, while selection for tolerance may allow animals to maintain performance despite infection.
  • A population can potentially benefit from genetic improvement in both traits. However, resistance and tolerance may have different genetic architectures and different consequences for pathogen transmission. Breeding objectives should therefore be designed according to the disease system and production environment.
  • Animal welfare is another important consideration. Increased disease susceptibility can lead to greater illness, treatment requirements, reduced productivity, pain, or mortality. Managing inbreeding and improving genetic resistance can therefore contribute to healthier and more resilient animals.
  • The economic importance of disease resistance is also substantial. Disease can reduce growth, milk production, meat production, egg production, fertility, longevity, and survival while increasing veterinary costs, medication use, labor requirements, and replacement costs. Genetic improvement can reduce some of these costs over generations.
  • Nevertheless, genetic selection should not be viewed as a substitute for veterinary care or disease prevention. Vaccination, biosecurity, nutrition, hygiene, housing, parasite control, disease surveillance, and appropriate treatment remain essential components of animal health management.
  • A successful breeding program should therefore combine genetic resistance with good management. Genetic improvement changes the underlying population’s ability to cope with disease, whereas management controls exposure and supports animals in expressing their genetic potential.
  • The relationship between inbreeding and disease resistance is also population-specific. A numerical inbreeding coefficient should not be interpreted as a universal predictor of disease outcomes. Different breeds and populations may have different levels of genetic load, different immune-related variation, different pathogen exposure, and different environmental conditions.
  • For this reason, monitoring should include multiple indicators. Useful information can include pedigree-based inbreeding, genomic inbreeding, ROH, disease incidence, disease severity, pathogen burden, survival, immune-response measurements, reproductive performance, and other health traits.
  • Long-term monitoring can reveal whether increasing inbreeding is accompanied by declining disease resistance or whether a breeding population is maintaining health despite changes in genetic relationships. Such monitoring is particularly important in small populations and breeds with limited numbers of breeding animals.
  • The objective is not to eliminate genetic relationships completely. Relatedness is unavoidable in closed or structured populations, and highly related animals can still carry valuable genetic combinations. The objective is to prevent excessive accumulation of homozygosity and genetic load while maintaining genetic progress.
  • Overall, inbreeding depression can affect disease resistance by increasing homozygosity, exposing deleterious recessive alleles, altering immune-related genetic variation, increasing genetic load, and potentially reducing resilience to infectious disease. The strength of these effects depends on the population, genetic architecture, pathogen, environment, management, and previous history of inbreeding.
  • Modern animal breeding provides several tools for managing these risks. Pedigree analysis, genomic relatedness, genomic inbreeding, ROH analysis, breeding values, BLUP, genomic selection, mate allocation, optimal contribution selection, and balanced selection indexes can be combined to improve disease resistance while controlling inbreeding.
  • The long-term goal is to develop populations that are healthy, disease-resistant, resilient, fertile, productive, genetically diverse, and sustainable. Genetic improvement for disease resistance is most effective when it is integrated with responsible management, strong animal-health programs, and careful preservation of genetic diversity.
Author: admin

Leave a Reply

Your email address will not be published. Required fields are marked *